We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chiron Rejects Novartis' $4.5 Billion Offer for Full Control
Chiron Rejects Novartis' $4.5 Billion Offer for Full Control
September 9, 2005
Chiron has rebuffed Novartis’ offer to acquire the biopharmaceutical firm, saying the $40 per share cash offer from its largest stockholder is “inadequate.”